Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jean L Chan, MD
Conatus Pharmaceuticals Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Institute for Liver Health
Chandler, Arizona, United States
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- St. Joseph'S Hospital & Medical Center
Phoenix, Arizona, United States
- University of Arizona Liver Research Institute
Tucson, Arizona, United States
- University of California, San Francisco-Fresno
Fresno, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Ucla Pfleger Liver Institute
Los Angeles, California, United States
- California Liver Research Institute
Pasadena, California, United States
- Stanford University
Redwood City, California, United States
- Inland Empire Liver Foundation
Rialto, California, United States
- Uc Davis Gi/hepatology Clinical Trials Unit
Sacramento, California, United States
- Scripps Clinic - Torrey Pines
San Diego, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California San Francisco
San Francisco, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Peak Enterology Associates
Colorado Springs, Colorado, United States
- West Haven Va Medical Center
West Haven, Connecticut, United States
- Uf Hepatology Research at Ctrb
Gainesville, Florida, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Florida Research Institute
Lakewood Rch, Florida, United States
- Schiff Center for Liver Disease/university of Miami
Miami, Florida, United States
- Florida Hospital Transplant Institute
Orlando, Florida, United States
- Imic Inc.
Palmetto Bay, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Piedmont Transplant Institute
Atlanta, Georgia, United States
- Gastrointestinal Specialists of Georgia
Marietta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Aquiant Research
Albany, Indiana, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics/ Internal Medicine
Iowa City, Iowa, United States
- Delta Research Partners
Bastrop, Louisiana, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Mercy Medical Center
Baltimore, Maryland, United States
- Walter Reed National Military Medical Center (wrnmmc)
Bethesda, Maryland, United States
- Digestive Disease Associates, Pa
Catonsville, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jun 2017
- Primary completion
- 31 Aug 2019
- Completion
- 31 Aug 2019
- Last update posted
- 19 Mar 2019
- Registered enrollment
- 210
- Registry id
- NCT03205345
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.